The pharmaceutical industry across North America and Europe has entered a period of radical reconstruction, driven by the convergence of maturing generative AI capabilities and the emergence of autonomous agentic systems. For Chief AI Officers (CAIOs) and senior leadership, the … Continue reading Research: Navigating the Maturity-Risk Matrix of the Modern Pharmaceutical Enterprise